molecular obesity

Molecular obesity is the slow, almost invisible weight gain that molecules undergo during optimization, when chemists keep adding groups to boost potency until the molecule has become large and greasy without anyone deciding it should. Like a project that grows heavier feature by feature, each addition seems reasonable, but the cumulative result is a bloated molecule.

The mechanism is simple and seductive. The easiest way to gain a bit of potency is often to add hydrophobic bulk that fills more of the pocket, and each such step nudges molecular weight and lipophilicity upward. No single change is alarming, but across many cycles the molecule drifts out of the comfortable druglike range, accumulating poor solubility, faster metabolism, and a higher chance of off-target effects and toxicity.

The term was coined as a deliberate warning. The cure is to track efficiency metrics like ligand efficiency and lipophilic ligand efficiency rather than potency alone, so the team notices when added bulk is buying potency at an unhealthy price. Recognizing molecular obesity early lets chemists trim the molecule back toward leanness before it becomes undevelopable.